These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19011322)

  • 21. [Optimization of the treatment of chronic obstructive pulmonary disease in men with androgen deficiency].
    Vertkin AL; Shakhmanaev AA
    Klin Med (Mosk); 2014; 92(11):38-42. PubMed ID: 25796945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late-Onset Hypogonadism and Testosterone Replacement in Older Men.
    Bhattacharya RK; Bhattacharya SB
    Clin Geriatr Med; 2015 Nov; 31(4):631-44. PubMed ID: 26476121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of testosterone on cardiovascular risk factors in men with type 2 diabetes and late-onset hypogonadism treated with metformin or glimepiride.
    Krysiak R; Gilowski W; Okopień B
    Pharmacol Rep; 2016 Feb; 68(1):75-9. PubMed ID: 26721356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous and exogenous testosterone levels after administration of deuterium-labelled testosterone propionate in hypogonadotropic hypogonadism.
    Fujioka M; Shinohara Y; Baba S; Irie M; Inoue K
    Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3100-1. PubMed ID: 2632058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial.
    Seidman SN; Spatz E; Rizzo C; Roose SP
    J Clin Psychiatry; 2001 Jun; 62(6):406-12. PubMed ID: 11465516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone.
    Reyes-Vallejo L; Lazarou S; Morgentaler A
    J Sex Med; 2007 Nov; 4(6):1757-62. PubMed ID: 17087806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of testosterone supplementation on symptoms in men with hypogonadism.
    Ramasamy R; Wilken N; Scovell JM; Lipshultz LI
    Eur Urol; 2015 Jan; 67(1):176-177. PubMed ID: 25199721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Testosterone normalizes plasma vasopressin response to osmotic stimuli in men with hypogonadism.
    Ikeda Y; Tanaka I; Oki Y; Gemmma R; Morita H; Komatsu K; Yoshimi T
    Endocr J; 1993 Aug; 40(4):387-92. PubMed ID: 7920892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of accurate testosterone testing in the treatment and management of male hypogonadism.
    Dobs AS
    Steroids; 2008 Dec; 73(13):1305-10. PubMed ID: 18639568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between testosterone levels, the metabolic syndrome (by two criteria), and insulin resistance in a population of men with organic erectile dysfunction.
    Guay A; Jacobson J
    J Sex Med; 2007 Jul; 4(4 Pt 1):1046-55. PubMed ID: 17627749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical Cogan's syndrome: a case report and summary of current treatment options.
    Jančatová D; Zeleník K; Komínek P; Matoušek P
    Int J Pediatr Otorhinolaryngol; 2015 Mar; 79(3):428-31. PubMed ID: 25600284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypogonadism management and cardiovascular health.
    Auerbach JM; Khera M
    Postgrad Med; 2020 Dec; 132(sup4):35-41. PubMed ID: 32799602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A long-acting depot formulation of testosterone (Aveed).
    Med Lett Drugs Ther; 2014 Mar; 56(1439):26-8. PubMed ID: 24691149
    [No Abstract]   [Full Text] [Related]  

  • 34. [The key role of testosterone in male hypogonadism].
    Arver S; Lehtihet M
    Lakartidningen; 2009 Sep 23-29; 106(39):2460-4. PubMed ID: 19852166
    [No Abstract]   [Full Text] [Related]  

  • 35. Atypical Cogan' syndrome associated with sudden deafness and glucocorticoid response.
    Montes S; Rodríguez-Muguruza S; Soria V; Olivé A
    Reumatol Clin; 2014; 10(4):267-8. PubMed ID: 24642232
    [No Abstract]   [Full Text] [Related]  

  • 36. Single-Centre Experience of Testosterone Therapy for Boys with Hypogonadism.
    Lucas-Herald AK; Mason E; Beaumont P; Mason A; Shaikh MG; Wong SC; Ahmed SF
    Horm Res Paediatr; 2018; 90(2):123-127. PubMed ID: 30021202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testosterone therapy: many players and much controversy.
    Sigman M
    Fertil Steril; 2015 May; 103(5):1144-5. PubMed ID: 25934600
    [No Abstract]   [Full Text] [Related]  

  • 38. Prediction of Long-term Post-operative Testosterone Replacement Requirement Based on the Pre-operative Tumor Volume and Testosterone Level in Pituitary Macroadenoma.
    Lee CC; Chen CM; Lee ST; Wei KC; Pai PC; Toh CH; Chuang CC
    Sci Rep; 2015 Nov; 5():16194. PubMed ID: 26537232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A neutral effect of testosterone therapy on macroprolactin content in men with macroprolactinemia and late-onset hypogonadism.
    Krysiak R; Kowalska B; Szkróbka W; Okopień B
    Pharmacol Rep; 2016 Feb; 68(1):139-43. PubMed ID: 26721365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to: Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
    Morgentaler A
    Int J Impot Res; 2008; 20(3):331; author reply 332. PubMed ID: 18475269
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.